Zdrowie i gospodarka · 12/06/2013

FDA Requests Public Comment on Proposed Information Collection for Investigational New Drug Safety Reporting and Bioavailability Studies

The Food and Drug Administration (FDA) is seeking public input on proposed information collection requirements for reporting safety data from human clinical trials and bioavailability studies, as mandated by the Paperwork Reduction Act of 1995.